While mutations leading to constitutive activation of this pathway are less common in GBM, they can result from upstream RTK activation, and cross-talk between the PI3K/Akt/mTOR and MAPK pathways contributes to tumor growth and resistance mechanisms [46]. This evidence concerns the gene PIK3CA and glioblastoma.